文献速递白内障与屈光手术

后房型有晶状体眼人工晶状体植入术:低中度与高度近视351眼的多中心比较研究

Posterior chamber phakic intraocular lens implantation: comparative, multicentre study in 351 eyes with low-to-moderate or high myopia.
PubMed 文献 · Br J Ophthalmol · 2017-06-13

这项多中心回顾性病例系列纳入351眼连续接受带中央孔的后房型有晶状体眼人工晶状体(ICL)植入术的患者,按术前近视程度分为低中度组57眼(等效球镜<-6 D)和高度组294眼(≥-6 D),比较术前及术后1天至12个月的安全性、有效性、可预测性、稳定性和不良事件。术后1年两组裸眼与矫正视力均良好,98%和99%的眼达到目标矫正度数±1.0 D以内,组2有2眼(0.7%)需更换ICL,未发生威胁视力的并发症,作者认为ICL对两种近视程度均表现良好且临床结果基本等同。

要点

  • 术后1年裸眼视力:低中度组-0.17±0.14 logMAR,高度组-0.16±0.09 logMAR。
  • 术后1年矫正视力:低中度组-0.21±0.10 logMAR,高度组-0.21±0.08 logMAR。
  • 低中度组98%与高度组99%的眼在目标矫正度数±1.0 D以内。

核心结论

  • ICL在1年观察期内对低中度近视和高度近视的矫正均表现良好。
  • ICL植入治疗低中度近视的临床结果与高度近视基本等同。

研究设计与样本

  • 多中心回顾性病例系列,纳入351例连续患者的351眼接受带中央孔的ICL(STAAR Surgical)植入术。
  • 按术前近视程度分组:组1为57眼,显性等效球镜<-6 D;组2为294眼,等效球镜≥-6 D。
  • 比较术前及术后1天、1周、1、3、6、12个月的安全性、有效性、可预测性、稳定性和不良事件。

主要发现

  • 术后1年裸眼视力:组1为-0.17±0.14 logMAR,组2为-0.16±0.09 logMAR。
  • 术后1年矫正视力:组1为-0.21±0.10 logMAR,组2为-0.21±0.08 logMAR。
  • 术后1年目标矫正度数±1.0 D以内:组1为98%,组2为99%。
  • 术后1天至1年显性屈光变化:组1为-0.12±0.34 D,组2为-0.18±0.43 D。
  • 组2有2眼(0.7%)需更换ICL,任何时间均未发生威胁视力的并发症。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To compare the clinical outcomes of posterior chamber phakic intraocular lens implantation with a central hole (Hole Implantable Collamer Lens (ICL), STAAR Surgical) for low-to-moderate myopia and for high myopia. METHODS: This multicentre retrospective case series comprised 351 eyes of 351 consecutive patients undergoing ICL implantation. Eyes were divided into groups based on preoperative degree of myopia: group 1; 57 eyes, manifest spherical equivalent less than -6 dioptres (D), and group 2; 294 eyes, -6 D or more. Safety, efficacy, predictability, stability and adverse events were compared preoperatively; and at 1 day, 1 week and 1, 3, 6 and 12 months postoperatively, RESULTS: Uncorrected and corrected visual acuities were -0.17±0.14 and -0.21±0.10 logMAR in group 1, and -0.16±0.09 and -0.21±0.08 logMAR in group 2, 1 year postoperatively. In groups 1 and 2, 98% and 99% of eyes were within 1.0 D of the targeted correction. Manifest refraction changes of -0.12±0.34 D (group 1) and -0.18±0.43 D (group 2) occurred from 1 day to 1 year. ICL exchanges were necessary in two eyes (0.7%) in group 2. No vision-threatening complications occurred at any time. CONCLUSIONS: The ICL performed well for the correction of both low-to-moderate myopia and high myopia throughout the 1-year observation period. The clinical outcomes of ICL implantation for low-to-moderate myopia are essentially equivalent to those for high myopia.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Kamiya K, Shimizu K, Igarashi A, et al. Posterior chamber phakic intraocular lens implantation: comparative, multicentre study in 351 eyes with low-to-moderate or high myopia. Br J Ophthalmol. 2017. PMID: 28611132. doi:10.1136/bjophthalmol-2017-310164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。